|
KCTD10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.77720085712008E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10709996725689E-09 |
| Normal-vs-Stage2 |
3.581500E-02 |
| Normal-vs-Stage3 |
1.0529355165545E-12 |
| Normal-vs-Stage4 |
1.02140518265514E-14 |
| Stage1-vs-Stage2 |
6.013800E-02 |
| Stage1-vs-Stage3 |
1.891800E-01 |
| Stage1-vs-Stage4 |
3.801000E-04 |
| Stage2-vs-Stage3 |
1.592490E-02 |
| Stage2-vs-Stage4 |
6.043000E-04 |
| Stage3-vs-Stage4 |
2.888200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14840026377294E-10 |
| Normal-vs-AfricanAmerican |
1.554410E-04 |
| Normal-vs-Asian |
2.63660000499044E-08 |
| Caucasian-vs-AfricanAmerican |
4.795600E-01 |
| Caucasian-vs-Asian |
9.365400E-01 |
| AfricanAmerican-vs-Asian |
4.205800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76289999159951E-10 |
| Normal-vs-Female |
3.6231995181879E-10 |
| Male-vs-Female |
6.321000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.13020745277026E-12 |
| Normal-vs-Age(41-60Yrs) |
4.80949999825953E-08 |
| Normal-vs-Age(61-80Yrs) |
2.14606110660043E-12 |
| Normal-vs-Age(81-100Yrs) |
3.000200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.080800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.823390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.438000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.711600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.177800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.587400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.17389999948681E-07 |
| Classical-VS-Follicular |
1.577430E-01 |
| Classical-VS-Other |
2.105200E-01 |
| Classical-VS-Normal |
3.66984220789845E-12 |
| Tall-VS-Follicular |
4.10339999999954E-05 |
| Tall-VS-Other |
6.930000E-01 |
| Tall-VS-Normal |
7.7715611723761E-16 |
| Follicular-VS-Other |
6.333700E-02 |
| Follicular-VS-Normal |
5.802500E-04 |
| Other-VS-Normal |
2.423600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.2321999783066E-09 |
| Normal-vs-N1 |
9.2370555648813E-14 |
| N0-vs-N1 |
1.358690E-03 |
|
|
